Featured Post

Latest Gold News

Gold may do even better in second half   Japan the new frontier for gold mining? Russia, China preparing to conduct energy transaction...

Wednesday, December 15, 2010

Health Management (NYSE:HMA) Revenue Growth, EBITDA Progressing

Health Management (NYSE:HMA) revenue growth and EBITDA continue to progress nicely, and Barclays (NYSE:BCS) raised their price on the acute care hospital chain.

Barclays said, "HMA has shown continued signs of progress with better-than-expected revenue growth and EBITDA. Overall revenues have been better than expected, due to higher-than-expected revenue per adjusted admission growth. With the revenue upside, EBITDA has been stronger than anticipated."

Barclays maintains an "Overweight" on Health Management, which closed Tuesday at $9.29, up $0.17, or 1.86 percent. They raised their price target on them from $10 to $11.

1 comment:

Anonymous said...

Il semble que vous soyez un expert dans ce domaine, vos remarques sont tres interessantes, merci.

- Daniel